Top Stories
The companies will co-develop a CNS candidate built around a newly-identified mechanism, sharing responsibilities from discovery through commercialisation.
The findings highlight the need to carefully integrate AI-based classification systems into healthcare.
The updated SimpleScreen CRC test outperformed Guardant Health's FDA-approved Shield test in detecting precancerous lesions.
The deal puts Cortechs.ai’s NeuroQuant MS inside Viz.ai’s hospital workflow, linking structured MRI analysis with the follow-up steps used to manage MS patients.
The startup’s AI prescription support platform will give the gastroenterology group a closer look at access delays affecting more than 60 million Americans living with digestive diseases.
Conference News
LONDON, July 13, 2026 (GLOBE NEWSWIRE) -- The same brain training shown in the past nine months to reduce the incidence of Alzheimer’s in the ACTIVE Study and to rejuvenate the production of the brain...
OXFORD, United Kingdom, July 13, 2026 (GLOBE NEWSWIRE) -- Oxford Brain Diagnostics (OBD), a leader in MRI-based measurement of brain health and neurodegenerative disease, today announced the presentat...
Presence builds on 205 original research articles documenting ALZpath's antibody use across Alzheimer's blood-based biomarker researchCARLSBAD, Calif., July 13, 2026 /PRNewswire/ -- ALZpath, Inc., a l...
Unbiased cerebrospinal fluid proteomics identify coordinated increases in HDL-like lipid transport proteins and myelination pathways following investigational Spectris™ sensory stimulationCAMBRIDGE, M...
Preliminary findings from one of China's largest prospective studies of non-invasive prenatal screening for dominant single-gene disorders (NIPT-SGD) were presented during the 30th International Confe...
